Study: Clarient's Mammostrat could help tailor breast cancer therapy
This article was originally published in Clinica
Executive Summary
Clarient's InsightDx Mammostrat test could help clinicians to decide which breast cancer patients should receive aggressive treatment, a study has suggested.